SuperworthOpus Genetics shares outstanding IRD
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 111.4M
- On a year earlier
- +75.8%
- more shares
Opus Genetics had 111.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 75.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 80.4M | +165% |
| FY2024 | 30.3M | +32% |
| FY2023 | 23M | +7% |
| FY2022 | 21.5M | +20% |
| FY2021 | 17.9M | +135% |
| FY2020 | 7.6M | +655% |
| FY2019 | 1M | +33% |
| FY2018 | 757.1K | +17% |
| FY2017 | 649.1K | +31% |
| FY2016 | 494.5K | +25% |
| FY2015 | 395.4K | +6% |
| FY2014 | 371.4K | +23% |
| FY2013 | 301.8K | +41% |
| FY2012 | 213.5K | +7% |
| FY2011 | 198.6K | +14% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 111.4M | +76% | |
| Q1 FY26 | 86.9M | +156% | |
| Q4 FY25 | 80.4M | +165% | |
| Q3 FY25 | 70.6M | +170% | |
| Q2 FY25 | 63.4M | +145% | |
| Q1 FY25 | 33.9M | +38% | |
| Q4 FY24 | 30.3M | +32% | |
| Q3 FY24 | 26.1M | +17% | |
| Q2 FY24 | 25.8M | +23% | |
| Q1 FY24 | 24.5M | +17% | |
| Q4 FY23 | 23M | +7% | |
| Q3 FY23 | 22.4M | +9% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Opus Genetics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.